Skip to content

About us
Our focus
Team
Investors
Drug pipeline
News
Contact

Menu

About us
Our focus
Team
Investors
Drug pipeline
News
Contact

Team

Home / Team

Management board

P. Victor Schut
Chief Executive Officer

Dr. Andreas A. Bastian
Chief Operating Officer & co-founder

Dr. Maria Bastian
Chief Science Officer

Dr. Frederik Deroose
Chief Knowledge Officer

External Consultant

Dr. Reinier Schwietert

Advisory Board

Prof. Dr. Andreas Herrmann

Prof. Jan Verhoef

About

AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections

Latest news

AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

7 April 2020

AGILeBiotics B.V. appoints new CEO Victor Schut

6 April 2020

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

28 November 2019

AGILeBiotics has been awarded the EUSMI-H2020 grant for up-scale synthesis of pre-clinical antibiotic candidate Toframicin

14 October 2019

Copyright © 2018 AGILeBiotics | All Rights Reserved. | Webdevelopment Skitter